NCT06050291View on ClinicalTrials.gov

Investigating the Effect of Food on the Bioavailability of a Fixed Dose Combination of Obicetrapib and Ezetimibe

PHASE1CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

January 20, 2024

Primary Completion Date

April 7, 2024

Study Completion Date

April 7, 2024

Conditions
Healthy Volunteer Study
Interventions
DRUG

Fixed-Dose Combination (FDC) Tablet

Obicetrapib/Ezetimibe FDC tablet

Trial Locations (1)

89121

NOVUM, Las Vegas

Sponsors
All Listed Sponsors
lead

NewAmsterdam Pharma

INDUSTRY